[Rheumatic patients in the intensive care unit]

Area of Science:

• Rheumatology
• Critical Care Medicine
• Immunology

Context:

• Patients with rheumatic diseases admitted to the intensive care unit (ICU) exhibit high mortality rates, even at younger ages.
• Differentiating between septic complications and autoimmune disease flares is diagnostically challenging in these patients.
• Managing complex antirheumatic therapies in critically ill individuals poses unique treatment difficulties.

Purpose:

• To provide an overview of the diagnostic and therapeutic challenges encountered in the intensive care unit for patients with autoimmune rheumatic diseases.
• To highlight the complexities in diagnosing underlying autoimmune conditions in critically ill patients.
• To discuss the management issues related to specific antirheumatic therapies in the ICU setting.

Summary:

• Critically ill patients with rheumatic diseases have high mortality, often complicated by diagnostic uncertainty and treatment complexities.
• Distinguishing between infection and disease flares is difficult, impacting appropriate management strategies.
• The intensive care unit environment presents unique hurdles for both diagnosing autoimmune conditions and administering specialized antirheumatic treatments.

Impact:

• Improved understanding of critical care challenges for rheumatic disease patients.
• Potential for enhanced diagnostic and treatment protocols in intensive care settings.
• A foundation for future research into optimizing outcomes for this vulnerable patient population.